Cargando…

Is Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV/Hepatitis C Co-Infected Cohorts

The effects of highly active antiretroviral therapy (HAART) on progression of hepatic fibrosis in HIV-hepatitis C virus (HCV) co-infection are not well understood. Deaths from liver diseases have risen in the post-HAART era, yet some cross-sectional studies have suggested that HAART use is associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moodie, Erica E. M., Pant Pai, Nitika, Klein, Marina B.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637977/ https://www.ncbi.nlm.nih.gov/pubmed/19223976 http://dx.doi.org/10.1371/journal.pone.0004517

Ejemplares similares

The Impact of Antiretroviral Therapy in a Cohort of HIV Infected Patients Going in and out of the San Francisco County Jail
por: Pant Pai, Nitika, et al.
Publicado: (2009)

Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
por: Brunet, Laurence, et al.
Publicado: (2016)

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
por: Sulyok, Mihály, et al.
Publicado: (2017)

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
por: Rossi, Carmine, et al.
Publicado: (2017)

Improving the Quality of Diagnostic Studies Evaluating Point of Care Tests for Acute HIV Infections: Problems and Recommendations
por: Smallwood, Megan, et al.
Publicado: (2017)

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono‐infection under long‐term combined antiretroviral therapy
por: Perazzo, Hugo, et al.
Publicado: (2018)

Point-of-Care Tests for HIV, Related Coinfections, and Blood-Borne Infections
por: Pant Pai, Nitika, et al.
Publicado: (2014)

Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection – The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index
por: Rollet-Kurhajec, Kathleen C., et al.
Publicado: (2015)

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
por: Benmassaoud, Amine, et al.
Publicado: (2018)

Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis
por: Brunet, Laurence, et al.
Publicado: (2013)

Systematic comparison of differential expression networks in MTB mono-, HIV mono- and MTB/HIV co-infections for drug repurposing
por: Jiang, Yao, et al.
Publicado: (2022)

Psoriasis and Liver Damage in HIV-Infected Patients
por: Busca Arenzana, Carmen, et al.
Publicado: (2021)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Molecular epidemiology of hepatitis B virus among HIV co-infected and mono-infected cohorts in Northwest Ethiopia
por: Belyhun, Yeshambel, et al.
Publicado: (2022)

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
por: Zerbato, Jennifer M., et al.
Publicado: (2022)

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study
por: Wittawatmongkol, Orasri, et al.
Publicado: (2015)

Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up
por: Kronfli, Nadine, et al.
Publicado: (2019)

Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996–2008)
por: Martinez-Cajas, Jorge L, et al.
Publicado: (2009)

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients
por: Rossi, Carmine, et al.
Publicado: (2018)

Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbidities
por: Cox, Joseph, et al.
Publicado: (2016)

Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada
por: Saeed, Sahar, et al.
Publicado: (2017)

World AIDS Day 2022: A bittersweet commemoration of the global HIV/AIDS response
por: Routy, Jean-Pierre, et al.
Publicado: (2022)

Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients
por: Hebeler-Barbosa, Flavia, et al.
Publicado: (2019)

Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers
por: Lombardi, Rosa, et al.
Publicado: (2017)

Comparative evaluation of baseline characteristics of HIV mono infected and HIV/HBV co infected cohort in eastern India
por: Sarkar, Jayeeta, et al.
Publicado: (2014)

Detection of Parvovirus 4 in Iranian patients with HBV, HCV, HIV mono-infection, HIV and HCV co-infection
por: Rastegarpouyani, Hosna, et al.
Publicado: (2018)

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection
por: Chalermchai, Thep, et al.
Publicado: (2013)

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in Canada
por: Kronfli, Nadine, et al.
Publicado: (2018)

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review
por: Bhargava, Madhavi, et al.
Publicado: (2014)

CMV and EBV Co-Infection in HIV-Infected Children: Infection Rates and Analysis of Differential Expression of Cytokines in HIV Mono- and HIV–CMV–EBV Co-Infected Groups
por: Nazim, Fizza, et al.
Publicado: (2022)

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients
por: Cooper, C, et al.
Publicado: (2015)

Characterization of the Intestinal Fungal Microbiome in HIV and HCV Mono-Infected or Co-Infected Patients
por: Yin, Yue, et al.
Publicado: (2022)

Impact of Round-the-Clock, Rapid Oral Fluid HIV Testing of Women in Labor in Rural India
por: Pai, Nitika Pant, et al.
Publicado: (2008)

Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008)

HIV Infection, Antiretroviral Therapy and Cardiovascular Risk
por: de Gaetano Donati, Katleen, et al.
Publicado: (2010)

Do digital innovations for HIV and sexually transmitted infections work? Results from a systematic review (1996-2017)
por: Daher, Jana, et al.
Publicado: (2017)

Implementation of an electronic patient-reported measure of barriers to antiretroviral therapy adherence with the Opal patient portal: Protocol for a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic
por: Engler, Kim, et al.
Publicado: (2021)

Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users
por: Ndombi, Eric M, et al.
Publicado: (2015)

Evaluation of Diagnostic Accuracy, Feasibility and Client Preference for Rapid Oral Fluid-Based Diagnosis of HIV Infection in Rural India
por: Pant Pai, Nitika, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_v8g9p253mukpbh1spjdul58clm